MedPath
FDA Approval

Pitavastatin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 10, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Pitavastatin(4.18 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Orient Pharma Co., Ltd.

658849810

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Orient Pharma Co., Ltd.

Teva Pharmaceuticals, Inc.

Orient Pharma Co., Ltd.

658849810

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pitavastatin

Product Details

NDC Product Code
0480-3633
Application Number
ANDA205932
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 10, 2023
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
MAGNESIUM OXIDEInactive
Code: 3A3U0GI71GClass: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
TRIACETINInactive
Code: XHX3C3X673Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
Code: IYD54XEG3WClass: ACTIMQuantity: 4.18 mg in 1 1

Pitavastatin

Product Details

NDC Product Code
0480-3631
Application Number
ANDA205932
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 10, 2023
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
MAGNESIUM OXIDEInactive
Code: 3A3U0GI71GClass: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
TRIACETINInactive
Code: XHX3C3X673Class: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
Code: IYD54XEG3WClass: ACTIMQuantity: 1.045 mg in 1 1
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT

Pitavastatin

Product Details

NDC Product Code
0480-3632
Application Number
ANDA205932
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 10, 2023
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
MAGNESIUM OXIDEInactive
Code: 3A3U0GI71GClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
TRIACETINInactive
Code: XHX3C3X673Class: IACT
Code: IYD54XEG3WClass: ACTIMQuantity: 2.09 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath